Jörg Sellmann

Vertically integrated German medicinal cannabis company DEMECAN announced the successful completion of its latest funding round on Wednesday. According to a person familiar with the matter, the new round brings DEMECAN's valuation close to 100 million euros ($109.24 million), reported Reuters. The...